Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upper airway muscle activity asleep
ACTRN12616000469415Phase 2Completed
- Sponsor
- Neuroscience Research Australia
- Start
- Apr 2016
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of reboxetine and scopolamine (2 arms), sponsored by Neuroscience Research Australia. Primary endpoint: Genioglossus muscle activity during sleep. Started Apr 2016; status: completed.
02
Drugs
reboxetinescopolamine
Beyond the preview
Go deeper on ACTRN12616000469415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000469415.